Atypical pathogen pneumonia

Current Opinion in Pulmonary Medicine

Volumn 3, Issue 2, 1997, Pages 111-115

  Lieberman, David ^a   Lieberman, Devora ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COMMUNICABLE DISEASE; HANTAVIRUS PULMONARY SYNDROME; HUMAN; LEGIONNAIRE DISEASE; MICROBIOLOGY; MYCOPLASMA PNEUMONIA; PNEUMONIA; REVIEW;

CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; HANTAVIRUS PULMONARY SYNDROME; HUMANS; LEGIONNAIRES' DISEASE; PNEUMONIA; PNEUMONIA, MYCOPLASMA;

EID: 0031088080     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199703000-00005     Document Type: Article

References (35)

1. Reimann HA: An acute infection of the respiratory tract with atypical pneumonia. JAMA 1938, 111:2377-2382.
2. Mundy LM, Auwaerter PG, Oldach D, Warner ML, Burton A, Vance E, Gaydos CA, Joseph JM, Gopalan R, Moore RD, et al.: Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995, 152:1309-1315. A series of 385 hospitalized CAP patients, of whom 57% were immunodepressed and 180 were HIV-positive. Streptococcus pneumoniae was the most common cause of CAP without association with immune status. The prevalence of all atypical pathogens together (chlamydia, legionella, and mycoplasma) was about 8% without difference in subanalysis by immune status classification.
3. Lieberman D, Schlaeffer F, Boldur I, Lieberman D, Horowitz S, Friedman MG, Leinonen M, Horovitz O, Manor E, Porath A: Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996, 51:179-184. A series of 346 adult patients hospitalized with CAP, with a comprehensive etiological work-up. An etiological diagnosis was obtained in 81% of the patients. More than one causative agent for CAP was identified in 38% of the patients. S. pneumoniae was identified in 43%. At least one of the three atypical pathogens was identified in 63% of the patients.
4. Jernigan DB, Hofmann J, Cetron MS, Genese CA, Nuorti JP, Fields BS, Benson RF, Carter RJ, Edelstein PH, Guerrero IC, Paul SM, Lipman HB, Breiman RF: Outbreak of Legionnaires' disease among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet 1996, 347:494-499.
5. Boswell TCJ, Marshall LE, Kudesia G: False-positive Legionella titres in routine clinical serology testing detected by absorption with Campylobacter: implications for the serological diagnosis of Legionnaires' disease. J Infect 1996, 32:23-26.
6. Lieberman D, Porath A, Schlaeffer F, Lieberman D, Boldur I: Legionella sp. community-acquired pneumonia: a review of 56 hospitalized adult patients. Chest 1995, 109:1243-1249. A description of 56 adult patients hospitalized with Legionella spp CAP. The disease presented with a broad spectrum of severity. There were no specific clinical, radiological, or routine laboratory features of the illness. In some of the patients, the disease appeared to be self-limited.
7. Pedro-Botet ML, Sabria-Leal M, Haro M, Rubio C, Gimenez G, Sopena N, Tor J: Nosocomial and community-acquired legionella pneumonia: clinical comparative analysis. Eur Respir J 1995, 8:1929-1933.
8. Kuzman I, Soldo I, Schonwald S, Culig J: Azithromycin for treatment of community-acquired pneumonia caused by Legionella pneumophila: a retrospective study. Scand J Infect Dis 1995, 27:503-505. Sixteen patients with Legionella pneumophila-caused CAP who were successfully treated with oral azithromycin at a total dosage of 1.5 g over 3 to 5 days are studied. All patients totally recovered without any significant adverse effects.
9. Edelstein PH: Antimicrobial chemotherapy for legionnaires' disease: a review. Clin Infect Dis 1995, 21(suppl 3):S-265-S-276.
10. Cosentini R, Blasi F, Raccanelli R, Rossi S, Arosia C, Tarsia P, Randazzo A, Allegra L: Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae. Respiration 1996, 63:61-65.
11. Blasi F, Consentini R, Raccanelli R, Rinaldi A, Denti F, Loprete F, Allegra L: Emerging pathogens of community-acquired pneumonia: a two-year prospective study. J Chemoth 1995, 7 (suppl 4):115-116.
12. Steinhoff D, Lode H, Ruckdeschel G, Heidrich B, Rolfs A, Fehrenbach FJ, Mauch H, Hoffken G, Wagner J: Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis 1996, 22:958-964.
13. Dalhoff K, Maass M: Chlamydia pneumoniae pneumonia in hospitalized patients. Chest 1996, 110:351-356. Diagnostic bronchoalveolar lavage was performed in 46 CAP patients. Using the polymerase chain reaction technique, Cp was identified in the bronchoalveolar lavage fluid of 15% of the patients. This method was shown to be very specific and much more sensitive than cell cultures. Cytological testing of the bronchoalveolar lavage fluid in patients with Cp CAP demonstrated lymphocytic alveolitis.
14. Lieberman D, Ben-Yaakov M, Lazarovich Z, Porath A, Schlaeffer F, Lieberman D, Leinonen M, Saikku P, Horovitz O, Boldur I: Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients. Infect 1995, 24:109-114. A series of 62 patients with Cp CAP. An additional causative agent was identified in the majority of patients, primarily S. pneumoniae. In comparison with other causes for CAP, the patients in this series were older and their disease was more serious, with longer periods of hospitalization. Some of the patients recovered despite having received therapy, which is not conventionally considered effective against this pathogen.
15. Kauppinen MT, Herva E, Kujala P, Leinonen M, Saikku P, Syrjala H: The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 1995, 172:1330-1335. A series of 125 adult CAP patients during an epidemic of Cp infection who underwent intensive etiological work-ups. A specific microbiological cause for CAP was identified in 88% of the patients. More than one causative agent was found in 38% of the patients. S. pneumoniae was identified in 55% and Cp in 43% of the patients.
16. Boschini A, Smacchia C, Di Fine M, Schiesari A, Ballarini P, Arlotti M, Gabrielli C, Castellani G, Genova M, Pantani P, et al.: Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis 1996, 23:107-113.
17. Kauppinen MT, Saikku P, Kujala P, Herva E, Syrjala H: Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996, 51:185-189. The clinical manifestations of Cp CAP and pneumococcal CAP were compared in three groups of patients. In two groups, one of these causes was found, whereas the third group was comprised of patients with both pathogens. Cp CAP was milder than pneumococcal CAP but had similar clinical features. The patients with both pathogens had a more severe clinical course with a longer period of hospitalization.
18. Panagou P, Tsipra S, Bouros D: Adult respiratory distress syndrome due to Chlamydia pneumoniae in a young adult. Respir Med 1996, 90:311-313.
19. Diehl J-L, Gisselbrecht M, Meyer G, Israel-Biet D, Sors H: Bronchiolitis obliterans organizing pneumonia associated with chlamydial infection. Eur Respir J 1996, 9:1320-1322. A description of a case of bronchiolitis obliterans organizing pneumonia, a complication of Cp CAP, in a 70-year-old man who did not recover from the illness despite appropriate antibiotic therapy.
20. Blasi F, Consentini R, Tarsia P, Camusso L, Campiu E, Arosio C, Allegra L: Chlamydia pneumoniae pneumonia: role of new macrolides. J Chemother 1995, 7(suppl 4):117-118. An analysis of the results of antibiotic therapy in 50 patients with Cp CAP. The new macrolides (clarithromycin and azithromycin) as well as tetracyclines were effective in the treatment of this disease both as initial therapy and as rescue therapy. Short-term therapy with erythromycin led to a high rate of relapse.
21. Tanaka H, Koba H, Honma S, Sugaya F, Abe S: Relationships between radiological pattern and cell-mediated immune response in Mycoplasma pneumoniae pneumonia. Eur Respir J 1996, 9:669-672. This original and interesting work describes 54 patients with Mp pneumonia who were divided by the pattern of pulmonary infiltrate on chest CT and the result of tuberculin skin testing. A nodular infiltrate with a centrilobar distribution was significantly associated with a positive tuberculin skin test. The investigators suggested that the results point to the possibility that features of cell-mediated immunity may affect the pattern of pulmonary lesions in Mp infection.
22. Lieberman D, Schlaeffer F, Lieberman D, Horowitz S, Horovitz O, Porath A: Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. Respiration 1996, 63:261-266. A series of 101 patients hospitalized with Mp CAP is reviewed. The disease was present primarily in younger patients but was also diagnosed among older and even elderly patients. The distribution of radiological findings was not significantly different from that of patients with CAP from other etiologies. Twenty-two percent of the patients recovered fully despite not having received antibiotic therapy, which is conventially considered effective against this pathogen.
23. Buck GE, Eid NS: Diagnosis of Mycoplasme pneumoniae pneumonia in pediatric patients by polymerase chain reaction (PCR). Pediatr Pulmonol 1995, 20:297-300.
24. Cimolai N, Wensley D, Seear M, Thomas ET: Mycoplasma pneumoniae as a cofactor in severe respiratory infections. Clin Infect Dis 1995, 21:1182-1185.
25. Shah DC, Muthiah MM: Adult respiratory distress syndrome due to mycoplasma pneumonia. Postgrad Med J 1996, 72:241-242.
26. Khan AS, Rollin PE, Hlady WG, Ksiazek TG, Armstrong LR, Greenman R, Ravkov E, Kolber M, Anapol H, Sfakianaki ED, Nichol ST, Peters CJ, Khabbaz RF: Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal Virus. Am J Med 1996, 100:46-48. A description of a case of HPS in Florida caused by a third and unknown strain of pathogenic American hantavirus, the Black Creek Canal hantavirus. This virus is transmitted by the S. hispidus (cotton rat). The disease is characterized by azotemia with acute respiratory distress syndrome. The investigators concluded that HPS is not limited to the geographical distribution of Peromyscus maniculatus and should be suspected in compatible clinical situations throughout the United States.
27. Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, Strine T, Miller G, Reef S, Tappero J, et al.: Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis 1996, 173:1297-1303.
28. MMWR Morbidity and Mortality Weekly Report: Hantavirus pulmonary syndrome: United States, 1995 and 1996. JAMA 1996, 275:1395-1397.
29. Auwaerter PG, Oldach D, Mundy LM, Burton A, Warner ML, Vance E, Moore RD, Rossi CA: Hantavirus serologies in patients hospitalized with community-acquired pneumonia. J Infect Dis 1996, 173:237-239.
30. Simonsen L, Dalton MJ, Breiman RF, Hennessy T, Umland ET, Sewell CM, Rollin PE, Ksiazek TG, Peters CJ: Evaluation of the magnitude of the 1993 hantavirus outbreak in the southwestern United States. J Infect Dis 1995, 172:729-733.
31. Vitek CR, Breiman RF, Ksiazek TG, Rollin PE, McLaughlin JC, Umland ET, Nolte KB, Loera A, Sewell CM, Peters CJ: Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis 1996, 22:824-826.
32. Nuovo GJ, Simsir A, Steigbigel RT, Kuschner M: Analysis of fatal pulmonary hantaviral infection in New York by reverse transcriptase in situ polymerase chain reaction. Am J Pathol 1996, 148:685-692. Using the reverse transcriptase in situ polymerase chain reaction technique, hantaviral cDNA was identified in about 20% of pneumocytes and alveolar endothelial cells in HPS patients, a much higher rate than in other tissues of the same patients. This finding points to a correlation between direct viral infection of the lungs and the disease process as well as a highly selective tropism of the hantavirus for the lungs.
33. Teglia OF, Battagliotti C, Villavicencio RL, Cunha BA: Leptospiral pneumonia. Chest 1995, 108:874-875.
34. To H, Kako N, Zhang GQ, Otsuka H, Ogawa M, Ochial O, Nguyen SV, Yamaguchi T, Fukushi H, Nagaoka N, Akiyama M, Amano K, Hirai K: Q fever pneumonia in children In Japan. J Clin Microbiol 1996, 34:647-651.
35. Sriskandan S, Labrecque LG, Schofield J: Diffuse pneumonia associated with infectious mononucleosis: detection of Epstein-Barr virus in lung tissue by in situ hybridization. Clin Infect Dis 1996, 22:578-579.